Subtype
Malignant Large Intestinal Neoplasm
CI-CAN-00003173Explore in graph →
1,622 active trials21 approved drugs383 evidence items
- NCIt
- C215202
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003173Explore in graph →
Clinical trials
7,502 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (742)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05963087 | Cetuximab in Combination With Dabrafenib and Tislelizumab in BRAF Mutated Treatment of Advanced Colorectal Cancer | unknown | N/A | 22 | Zhejiang Cancer HospitalOTHER | 1 | Jul 27, 2023 | clinicaltrials |
| NCT05916443 | Dissecting the Biology of Early-onset Colorectal Cancer | unknown | — | 30 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 0 | Jul 24, 2023 |
| NCT05957744 | Nutritional Risk Factors and Colorectal Surgery | unknown | — | 120 | University Clinic Dr Dragisa Misovic-DedinjeOTHER | 1 | Jul 24, 2023 | clinicaltrials |
| NCT05726188 | Predictors of Disease Recurrence After Curative Surgery for Stage I Colon Cancer(CORE1) | unknown | — | 2,000 | Azienda Ospedaliera Universitaria Integrata VeronaOTHER | 2 | Jul 21, 2023 | clinicaltrials |
| NCT05928312 | Fruquintinib Combined With Chemotherapy as Third-line /Third-line+ Treatment in Advanced Colorectal Cancer | unknown | N/A | 72 | Zhejiang Cancer HospitalOTHER | 1 | Jul 20, 2023 | clinicaltrials |
| NCT05871333 | Effect of Losartan on the Incidence and Severity of Chemotherapy-Induced Mucositis in Gastrointestinal Cancer Patients | unknown | Phase 2 | 80 | Ain Shams UniversityOTHER | 1 | Jul 19, 2023 | clinicaltrials |
| NCT04653480 | Surufatinib, Toripalimab and Chemotherapy in Second-line MT and MSS CRC | unknown | Phase 2 | 61 | Zhejiang UniversityOTHER | 1 | Jul 17, 2023 | clinicaltrials |
| NCT05089266 | Study of αPD1-MSLN-CAR T Cells to Evaluate the Safety, Tolerability, and Effectiveness for Patients With MSLN-positive Advanced Solid Tumors | unknown | Phase 1 | 30 | Shanghai Cell Therapy Group Co.,LtdINDUSTRY | 1 | Jul 17, 2023 | clinicaltrials |
| NCT05948072 | Cetuximab+mFOLFOX6 VS. mFOLFOX6 Alone in RAS/BRAF Wild Type Patients With High-Risk Resectable CRLM | unknown | Phase 3 | 250 | Fudan UniversityOTHER | 1 | Jul 17, 2023 | clinicaltrials |
| NCT05818267 | Efficacy and Safety of Regorafenib Maintenance Therapy in Patients With Metastatic Colorectal Cancer (mCRC) | unknown | N/A | 30 | Wei ZhangOTHER | 1 | Jul 14, 2023 | clinicaltrials |
| NCT05945082 | Fusobacterium Nucleatum at Colorectal Cancer Sites | unknown | N/A | 150 | Malmö UniversityOTHER | 1 | Jul 14, 2023 | clinicaltrials |
| NCT05877573 | Toripalimab Combined With Neoadjuvant Chemoradiotherapy as First-line Treatment for Locally Advanced，High-Risk，MSS Rectal Cancer | unknown | N/A | 53 | Nanfang Hospital, Southern Medical UniversityOTHER | 1 | Jul 5, 2023 | clinicaltrials |
| NCT05832398 | Precision Chemotherapy Based on Organoid Drug Sensitivity for Colorectal Cancer | unknown | N/A | 186 | Nanfang Hospital, Southern Medical UniversityOTHER | 1 | Jun 28, 2023 | clinicaltrials |
| NCT05911152 | Safety and Feasibility of Laparoscopic Intracorporeal Anastomosis for Colorectal Surgery- A Multiple Center Real World Study(SELECTED) | unknown | — | 2,000 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Jun 27, 2023 | clinicaltrials |
| NCT05920928 | Comparison of the Clinical Response of Total Neoadjuvant Treatment of Two Methods of Long-term or Short-term Chemoradiotherapy in Rectal Cancer(TEHRAN) | unknown | N/A | 114 | Tehran University of Medical SciencesOTHER | 0 | Jun 27, 2023 | clinicaltrials |
| NCT05785975 | Effectiveness of Modified Integrated Colorectal Cancer Screening System in Saudi Arabia(ColonCancer) | unknown | N/A | 2,520 | The New Model of Care, Hail Health ClusterOTHER_GOV | 1 | Jun 26, 2023 | clinicaltrials |
| NCT05916001 | Preoperative Immunonutrition in Patients Undergoing Elective Colorectal Surgery for Neoplasm | unknown | N/A | 216 | University of Roma La SapienzaOTHER | 0 | Jun 23, 2023 | clinicaltrials |
| NCT02560298 | Cisplatin and Fluorouracil Compared With Carboplatin and Paclitaxel in Treating Patients With Inoperable Locally Recurrent or Metastatic Anal Cancer(InterAACT) | unknown | Phase 2 | 91 | ECOG-ACRIN Cancer Research GroupNETWORK | 1 | Jun 22, 2023 | clinicaltrials |
| NCT05374044 | Establishment of MRI Model for pTRG in Rectal Cancer With Establishment of | unknown | — | 385 | Peking University Cancer Hospital & InstituteOTHER | 1 | Jun 22, 2023 | clinicaltrials |
| NCT05913570 | Cadonilimab as Neoadjuvant Therapy in Resectable Stage II-III MSI-H/dMMR Colorectal Cancer(MSI-H/dMMR) | unknown | Phase 2 | 22 | LiuYingOTHER_GOV | 1 | Jun 22, 2023 | clinicaltrials |
| NCT05914597 | Trial Feasibility of Home Delivery of Colon Capsule Endoscopy Service With the Help of 5 G Technology(5GSUCCEEDS) | unknown | N/A | 25 | National Health Service, United KingdomOTHER_GOV | 1 | Jun 22, 2023 | clinicaltrials |
| NCT05910099 | Taking a Look at Patient Experiences In Rectal Cancer Clinical Trials | unknown | — | 500 | Power Life Sciences Inc.INDUSTRY | 1 | Jun 18, 2023 | clinicaltrials |
| NCT05247346 | Early Detection of Cancer Onset Based on Sensing Field Cancerization at the Organ Level in the Alimentary Tract Using an Integrated Stimulated Raman/Scattering Modality for Endoscopic Real-time in Vivo Measurements(SENSITIVE) | unknown | N/A | 60 | University Medical Center GroningenOTHER | 1 | Jun 13, 2023 | clinicaltrials |
| NCT05715905 | Analyzing Clinical Trial Experiences of Colon Cancer Patients | unknown | — | 500 | Power Life Sciences Inc.INDUSTRY | 0 | Jun 12, 2023 | clinicaltrials |
| NCT03073694 | Comparing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) Using Mitomycin-C Versus Melphalan for Colorectal Peritoneal Carcinomatosis | unknown | Phase 2 | 100 | University of Kansas Medical CenterOTHER | 1 | Jun 9, 2023 | clinicaltrials |
| NCT05250791 | Feasibility Study of Lidocaine Infusion During Bowel Cancer Surgery for Cancer Outcome(FLICOR) | unknown | N/A | 50 | Imperial College LondonOTHER | 1 | Jun 9, 2023 | clinicaltrials |
| NCT05897749 | Clinical Study on the Effect of Brucea Javanica Oil Emulsion Injection on the Survival of Patients With Advanced Colorectal Cancer Who Failed to Receive Multi-line Treatment | unknown | Phase 4 | 60 | Guang'anmen Hospital of China Academy of Chinese Medical SciencesOTHER | 1 | Jun 9, 2023 | clinicaltrials |
| NCT05160896 | SALIRI Based Regimen as First-line Treatment for Advanced Metastatic Colorectal Cancer | unknown | Phase 2 | 90 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Jun 8, 2023 | clinicaltrials |
| NCT05891028 | 64Cu/68Ga Labelled EB-ss-CPT PET/CT Scan in Colorectal Cancer | unknown | Early Phase 1 | 10 | Peking Union Medical College HospitalOTHER | 1 | Jun 8, 2023 | clinicaltrials |
| NCT05894837 | Serplulimab+Regorafenib +Hepatic Artery Bicarbonate Infusion in Patients With Colorectal Cancer and Liver Metastases | unknown | Phase 2 | 30 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Jun 8, 2023 | clinicaltrials |
| NCT05780307 | IMM2520, a PD-L1 and CD47 Bispecific Antibody in Patients With Advanced Solid Tumors | unknown | Phase 1 | 48 | ImmuneOnco Biopharmaceuticals (Shanghai) Inc.OTHER | 1 | Jun 7, 2023 | clinicaltrials |
| NCT05891730 | Examination of Trends in Colorectal Cancer Patients' Clinical Study Experiences | unknown | — | 500 | Power Life Sciences Inc.INDUSTRY | 1 | Jun 7, 2023 | clinicaltrials |
| NCT05790590 | Comparison of Image Quality Between "Double Low Dose" Liver CT and Standard Liver CT | unknown | N/A | 176 | Seoul National University HospitalOTHER | 1 | Jun 5, 2023 | clinicaltrials |
| NCT05886075 | A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors | unknown | Early Phase 1 | 24 | Shanghai Yunying Medical TechnologyINDUSTRY | 1 | Jun 2, 2023 | clinicaltrials |
| NCT03831698 | Omega 3 Fatty Acids in Colorectal Cancer (CRC) Prevention in Patients With Lynch Syndrome (COLYNE) | unknown | Phase 2 | 21 | University of Kansas Medical CenterOTHER | 1 | Jun 1, 2023 | clinicaltrials |
| NCT05438771 | The Effects of Ankaferd Blood Stopper(ABS) | unknown | N/A | 66 | Uludag UniversityOTHER | 1 | Jun 1, 2023 | clinicaltrials |
| NCT04083365 | Capecitabine Plus Concomitant Radiation Therapy Followed by Durvalumab as Preoperative Treatment in Rectal Cancer(PANDORA) | unknown | Phase 2 | 100 | AUSL Romagna RiminiOTHER | 1 | May 31, 2023 | clinicaltrials |
| NCT05233332 | Study of HL-085 and Vemurafinib in Metastatic Colorectal Cancer (mCRC)(mCRC) | unknown | Phase 2 | 186 | Shanghai Kechow Pharma, Inc.INDUSTRY | 1 | May 31, 2023 | clinicaltrials |
| NCT05596188 | Anxiety Before Non-cardiac Surgery in Adults | unknown | — | 424 | RenJi HospitalOTHER | 1 | May 31, 2023 | clinicaltrials |
| NCT05882396 | Rood's Approach and Oxaliplatin-induced Peripheral Neuropathy in Colorectal Cancer Patients | unknown | N/A | 60 | Cairo UniversityOTHER | 0 | May 31, 2023 | clinicaltrials |
| NCT05879861 | Development and Validation of a Risk Prediction Model for Preoperative Frailty in Elderly Patients With Colorectal Cancer | unknown | — | 364 | Zunyi Medical CollegeOTHER | 1 | May 30, 2023 | clinicaltrials |
| NCT03189576 | Measuring Molecular Residual Disease in Colorectal Cancer After Primary Surgery and Resection of Metastases | unknown | N/A | 37 | Tampere University HospitalOTHER | 1 | May 26, 2023 | clinicaltrials |
| NCT04233151 | QL1203 In Combination With Chemotherapy for Metastatic Colorectal Cancer to Determine Efficacy and Safety | unknown | Phase 3 | 590 | Qilu Pharmaceutical Co., Ltd.INDUSTRY | 1 | May 26, 2023 | clinicaltrials |
| NCT05799820 | QL1706 Monotherapy or in Combination With Bevacizumab and XELOX as First-line Treatment of Unresectable Advanced or Metastatic CRC | unknown | Phase 2 | 60 | Qilu Pharmaceutical Co., Ltd.INDUSTRY | 1 | May 25, 2023 | clinicaltrials |
| NCT05875402 | XKDCT080 in GCC-positive Recurrent or Refractory Solid Tumors With Single Center, Single Arm, and Dose Escalation | unknown | N/A | 9 | The Affiliated Hospital of Qingdao UniversityOTHER | 1 | May 25, 2023 | clinicaltrials |
| NCT05243771 | Norwegian Stoma Trial | unknown | — | 400 | The Hospital of VestfoldOTHER | 1 | May 24, 2023 | clinicaltrials |
| NCT05873621 | Indocyanine Green-guided Lymphadenectomy in Laparoscopic Total Mesorectal Excision for Low Rectal Cancer After Neoadjuvant Chemoradiotherapy((GreenEye-CRC)) | unknown | N/A | 60 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | May 24, 2023 | clinicaltrials |
| NCT05868317 | Induction Chemotherapy Followed by Short Course Radiotherapy in Rectal Cancer | unknown | Phase 2 | 70 | Salah Azaïz Cancer InstituteOTHER | 1 | May 22, 2023 | clinicaltrials |
| NCT03737539 | Dynamic Monitoring of ctDNA Methylation to Predict Relapse in Colorectal Cancer After Radical Resection (POSTCA) | unknown | — | 300 | Fudan UniversityOTHER | 1 | May 19, 2023 | clinicaltrials |
| NCT05382741 | Adjuvant Durvalumab Plus Regorafenib vs Untreated Control in Stage IV Colorectal Cancer Patients With no Evidence of Disease (NED): VIVA Trial(VIVA) | unknown | Phase 2 | 182 | Ospedale Policlinico San MartinoOTHER | 1 | May 17, 2023 | clinicaltrials |
Data updated 23 days agoSource updated Jul 27, 2023source: clinicaltrials